
Ophthalmologist

No OPD information available
Uveitis
Age-Related Macular Degeneration (ARMD)
Cataract
Cataract Removal
Episcleritis
Lacrimal Gland Tumor
Late-Onset Retinal Degeneration
Lymphofollicular Hyperplasia
Retinopathy Pigmentary Mental Retardation
Sarcoidosis
Scleritis
Richard J. Stawell is a male eye doctor who helps people with eye problems like Uveitis, Age-Related Macular Degeneration (ARMD), Cataract, Episcleritis, and more. He is skilled in treating these eye issues and helping patients feel better.
Dr. Stawell talks to his patients in a friendly way and listens to their concerns. Patients trust him because he explains things clearly and makes them feel comfortable. He cares about their well-being and wants to help them see better.
To stay updated with the latest medical knowledge, Dr. Stawell reads research papers and attends conferences. This helps him learn new treatments and techniques to improve his patients' eye health.
Dr. Stawell works well with other doctors and medical professionals. He shares his knowledge and collaborates with them to give the best care to his patients. His colleagues respect him for his expertise and dedication to helping people with eye problems.
Through his work, Dr. Stawell has made a positive impact on many patients' lives. His treatments have helped people see better and feel more comfortable with their eye conditions. Patients appreciate his kindness and skill in treating their eye issues.
One of Dr. Stawell's notable publications is about cataract surgery in patients with Uveitis. He also conducted a clinical trial to study treatments for macular edema. These studies help improve eye care for patients with different eye problems.
In conclusion, Dr. Richard J. Stawell is a caring and skilled eye doctor who works hard to help his patients with various eye conditions. His dedication to staying updated with medical knowledge and collaborating with other professionals shows his commitment to providing the best care for his patients.
Enrollment Status: Completed
Published: July 10, 2023
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
